Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction

Published:2020-12 Issue:23 Volume:76 Page:2740-2751
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Omar Massar,Jensen Jesper,Frederiksen Peter H.,Kistorp Caroline,Videbæk Lars,Poulsen Mikael Kjær,Möller Sören,Ali Mulham,Gustafsson Finn,Køber Lars,Borlaug Barry A.,Schou Morten,Møller Jacob Eifer

Funder

Hjerteforeningen

A.P. Møller og Hustru Chastine Mc-Kinney Møllers Fond til almene Formaal

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

2. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med,2018

3. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

4. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME trial;Fitchett;Eur Heart J,2016

5. Cardiovascular and renal outcomes with empagliflozin in heart failure;Packer;N Engl J Med,2020

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haemodynamic Effects of Sodium–Glucose Cotransporter 2 Inhibitor Treatment in Chronic Heart Failure Patients;Cardiac Failure Review;2024-09-11

2. Cardioprotective Effect of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients: A Multicenter Propensity Score Matched Study;Kidney International Reports;2024-08

3. Association between early central venous pressure measurement and all-cause mortality in critically ill patients with heart failure: A cohort of 11,241 patients;Heliyon;2024-07

4. Pharmacological and Non-Pharmacological Advancements in Heart Failure Treatment;Reviews in Cardiovascular Medicine;2024-06-25

5. Ventricular remodeling and hemodynamic changes in heart failure patients with non-ischemic dilated cardiomyopathy following dapagliflozin initiation;The Egyptian Heart Journal;2024-06-18